ReP USP - Resultado da busca

Artigo de periodico
Tartrolon D induces immunogenic cell death in melanoma (2024)
Brito, Thaís Lima de ; Edson, Evelline Araújo ; Florêncio, Katharine Gurgel Dias ; Garnique, Anali Del Milagro Bernabe ; Luiz, João Paulo Mesquita ; Haygood, Margo ; Wilke, Diego Veras ; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Machado Neto, João Agostinho
Source: Chemico-Biological Interactions. Unidades: FMRP, ICB
Subjects: FARMACOLOGIA, MELANOMA, CÉLULAS MORTAS, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, RETÍCULO ENDOPLASMÁTICO, ANTINEOPLÁSICOS, IMUNOTERAPIA, CAMUNDONGOS, APOPTOSE, CITOMETRIA DE FLUXO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITO, Thaís Lima de et al. Tartrolon D induces immunogenic cell death in melanoma. Chemico-Biological Interactions, v. 400, p. 11 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2024.111177. Acesso em: 31 out. 2024.
APA
Brito, T. L. de, Edson, E. A., Florêncio, K. G. D., Garnique, A. D. M. B., Luiz, J. P. M., Haygood, M., et al. (2024). Tartrolon D induces immunogenic cell death in melanoma. Chemico-Biological Interactions, 400, 11 . doi:10.1016/j.cbi.2024.111177
NLM
Brito TL de, Edson EA, Florêncio KGD, Garnique ADMB, Luiz JPM, Haygood M, Wilke DV, Cunha F de Q, Alves Filho JCF, Machado Neto JA. Tartrolon D induces immunogenic cell death in melanoma [Internet]. Chemico-Biological Interactions. 2024 ; 400 11 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.cbi.2024.111177
Vancouver
Brito TL de, Edson EA, Florêncio KGD, Garnique ADMB, Luiz JPM, Haygood M, Wilke DV, Cunha F de Q, Alves Filho JCF, Machado Neto JA. Tartrolon D induces immunogenic cell death in melanoma [Internet]. Chemico-Biological Interactions. 2024 ; 400 11 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.cbi.2024.111177
Artigo de periodico
Long-term glucocorticoid infusion impairs epididymal adipocyte metabolism and maturation and affects miR-150–5p actions (2024)
Salgueiro, Rafael Barrera ; Bolin, Anaysa Paola ; Andreotti, Sandra ; Komino, Ayumi Cristina Medeiros ; Sousa, Érica de; Silva, Flaviane de Fatima ; Proença, André Ricardo Gomes de ; Sertie, Rogério Antonio Laurato ; Rodrigues, Alice Cristina ; Lima, Fabio Bessa
Source: Molecular and Cellular Endocrinology. Unidades: ICB, FCF
Subjects: FISIOLOGIA, FARMACOLOGIA, HORMÔNIOS GLICOCORTICOIDES, TECIDO ADIPOSO, MICRORNAS, APOPTOSE, DOENÇAS METABÓLICAS, LIPÍDEOS, GORDURAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALGUEIRO, Rafael Barrera et al. Long-term glucocorticoid infusion impairs epididymal adipocyte metabolism and maturation and affects miR-150–5p actions. Molecular and Cellular Endocrinology, v. 589, p. 12 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.mce.2024.112250. Acesso em: 31 out. 2024.
APA
Salgueiro, R. B., Bolin, A. P., Andreotti, S., Komino, A. C. M., Sousa, É. de, Silva, F. de F., et al. (2024). Long-term glucocorticoid infusion impairs epididymal adipocyte metabolism and maturation and affects miR-150–5p actions. Molecular and Cellular Endocrinology, 589, 12 . doi:10.1016/j.mce.2024.112250
NLM
Salgueiro RB, Bolin AP, Andreotti S, Komino ACM, Sousa É de, Silva F de F, Proença ARG de, Sertie RAL, Rodrigues AC, Lima FB. Long-term glucocorticoid infusion impairs epididymal adipocyte metabolism and maturation and affects miR-150–5p actions [Internet]. Molecular and Cellular Endocrinology. 2024 ; 589 12 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.mce.2024.112250
Vancouver
Salgueiro RB, Bolin AP, Andreotti S, Komino ACM, Sousa É de, Silva F de F, Proença ARG de, Sertie RAL, Rodrigues AC, Lima FB. Long-term glucocorticoid infusion impairs epididymal adipocyte metabolism and maturation and affects miR-150–5p actions [Internet]. Molecular and Cellular Endocrinology. 2024 ; 589 12 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.mce.2024.112250
Artigo de periodico
Uncovering metabolic alterations in HCT-116 colon cancer cells upon exposure to bamboo leaf extract obtained from Guadua incana Londoño (2024)
Chitiva, Luis Carlos ; Santamaría-Torres, Mary Andrea; Rezende-Teixeira, Paula ; Borlot, Jessica Rodrigues Pereira de Oliveira ; Romagna, Rodrigo de Almeida ; Londoño, Ximena ; Kitagawa, Rodrigo Rezende ; Prieto-Rodríguez, Julieth A. ; Castro-Gamboa, Ian ; Costa, Geison Modesti ; Costa-Lotufo, Leticia Veras
Source: Molecules: a journal of synthetic organic and natural product chemistry. Unidade: ICB
Subjects: FARMACOLOGIA, PRODUTOS NATURAIS, FOLHAS (PLANTAS), EXTRATOS (FORMAS FARMACÊUTICAS), ANTI-INFLAMATÓRIOS, NEOPLASIAS DO COLON, CÉLULAS CULTIVADAS DE TUMOR, METABOLÔMICA, CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS, APOPTOSE, BAMBU
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHITIVA, Luis Carlos et al. Uncovering metabolic alterations in HCT-116 colon cancer cells upon exposure to bamboo leaf extract obtained from Guadua incana Londoño. Molecules: a journal of synthetic organic and natural product chemistry, v. 29, n. 13, p. 28 , 2024Tradução . . Disponível em: https://doi.org/10.3390/molecules29132985. Acesso em: 31 out. 2024.
APA
Chitiva, L. C., Santamaría-Torres, M. A., Rezende-Teixeira, P., Borlot, J. R. P. de O., Romagna, R. de A., Londoño, X., et al. (2024). Uncovering metabolic alterations in HCT-116 colon cancer cells upon exposure to bamboo leaf extract obtained from Guadua incana Londoño. Molecules: a journal of synthetic organic and natural product chemistry, 29( 13), 28 . doi:https://doi.org/10.3390/molecules29132985
NLM
Chitiva LC, Santamaría-Torres MA, Rezende-Teixeira P, Borlot JRP de O, Romagna R de A, Londoño X, Kitagawa RR, Prieto-Rodríguez JA, Castro-Gamboa I, Costa GM, Costa-Lotufo LV. Uncovering metabolic alterations in HCT-116 colon cancer cells upon exposure to bamboo leaf extract obtained from Guadua incana Londoño [Internet]. Molecules: a journal of synthetic organic and natural product chemistry. 2024 ; 29( 13): 28 .[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/molecules29132985
Vancouver
Chitiva LC, Santamaría-Torres MA, Rezende-Teixeira P, Borlot JRP de O, Romagna R de A, Londoño X, Kitagawa RR, Prieto-Rodríguez JA, Castro-Gamboa I, Costa GM, Costa-Lotufo LV. Uncovering metabolic alterations in HCT-116 colon cancer cells upon exposure to bamboo leaf extract obtained from Guadua incana Londoño [Internet]. Molecules: a journal of synthetic organic and natural product chemistry. 2024 ; 29( 13): 28 .[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/molecules29132985
Artigo de periodico
2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) inhibits proliferation and invasion via senescence pathway induction in human BRAFi-Resistant melanoma cells (2023)
Franco, Ylana Adami; Moraes Jr., Manoel de Oliveira ; Carvalho, Larissa A. C. ; Dohle, Wolfgang ; Potter, Barry V. L. ; Silva, Renaira Oliveira da ; Noma, Isabella Harumi Yonehara ; Maria-Engler, Silvya Stuchi ; Lima, Keli ; Machado Neto, João Agostinho
Source: International Journal of Molecular Sciences. Unidades: ICB, FCF, FM
Subjects: FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, HORMÔNIOS SEXUAIS FEMININOS, ESTRADIOL, PROLIFERAÇÃO CELULAR, ANTINEOPLÁSICOS, MELANOMA, NEOPLASIAS EMBRIONÁRIAS DE CÉLULAS GERMINATIVAS, APOPTOSE, ENVELHECIMENTO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCO, Ylana Adami et al. 2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) inhibits proliferation and invasion via senescence pathway induction in human BRAFi-Resistant melanoma cells. International Journal of Molecular Sciences, v. 24, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.3390/ijms241411314. Acesso em: 31 out. 2024.
APA
Franco, Y. A., Moraes Jr., M. de O., Carvalho, L. A. C., Dohle, W., Potter, B. V. L., Silva, R. O. da, et al. (2023). 2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) inhibits proliferation and invasion via senescence pathway induction in human BRAFi-Resistant melanoma cells. International Journal of Molecular Sciences, 24, 1-16. doi:10.3390/ijms241411314
NLM
Franco YA, Moraes Jr. M de O, Carvalho LAC, Dohle W, Potter BVL, Silva RO da, Noma IHY, Maria-Engler SS, Lima K, Machado Neto JA. 2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) inhibits proliferation and invasion via senescence pathway induction in human BRAFi-Resistant melanoma cells [Internet]. International Journal of Molecular Sciences. 2023 ; 24 1-16.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/ijms241411314
Vancouver
Franco YA, Moraes Jr. M de O, Carvalho LAC, Dohle W, Potter BVL, Silva RO da, Noma IHY, Maria-Engler SS, Lima K, Machado Neto JA. 2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) inhibits proliferation and invasion via senescence pathway induction in human BRAFi-Resistant melanoma cells [Internet]. International Journal of Molecular Sciences. 2023 ; 24 1-16.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/ijms241411314
Artigo de periodico
The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells (2023)
Lima, Keli ; Miranda, Lívia Bassani Lins De ; Garnique, Anali Del Milagro Bernabe ; Almeida, Bruna Oliveira de ; Nascimento, Mariane Cristina do; Alcântara, Guilherme Augusto Sousa; Machado-Santelli, Glaucia Maria ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Cancers. Unidades: ICB, FM
Subjects: BIOLOGIA CELULAR, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS PANCREÁTICAS, INIBIDORES DE ENZIMAS, ANTINEOPLÁSICOS, DANO AO DNA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells. Cancers, v. 15, n. 15, p. 14 , 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15153866. Acesso em: 31 out. 2024.
APA
Lima, K., Miranda, L. B. L. D., Garnique, A. D. M. B., Almeida, B. O. de, Nascimento, M. C. do, Alcântara, G. A. S., et al. (2023). The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells. Cancers, 15( 15), 14 . doi:10.3390/cancers15153866
NLM
Lima K, Miranda LBLD, Garnique ADMB, Almeida BO de, Nascimento MC do, Alcântara GAS, Machado-Santelli GM, Rego EM, Machado Neto JA. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells [Internet]. Cancers. 2023 ; 15( 15): 14 .[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/cancers15153866
Vancouver
Lima K, Miranda LBLD, Garnique ADMB, Almeida BO de, Nascimento MC do, Alcântara GAS, Machado-Santelli GM, Rego EM, Machado Neto JA. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells [Internet]. Cancers. 2023 ; 15( 15): 14 .[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/cancers15153866
Artigo de periodico
Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models (2023)
Nascimento, Mariane Cristina do ; Martins, Diego Antonio Pereira ; Alcântara, Guilherme Augusto Sousa; Lima, Keli Cristina de ; Vicari, Hugo Passos ; Huls, Gerwin A. ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Ferreira, Marcelo José Pena ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: IB, FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, HEMATOLOGIA, QUIMIOTERAPIA COMBINADA, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR, NEOPLASIAS POR TIPO HISTOLÓGICO, APOPTOSE, DANO AO DNA, MITOCÔNDRIAS, PROTEÔMICA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Mariane Cristina do et al. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, v. 142, n. res. 604, p. 5751, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189814. Acesso em: 31 out. 2024.
APA
Nascimento, M. C. do, Martins, D. A. P., Alcântara, G. A. S., Lima, K. C. de, Vicari, H. P., Huls, G. A., et al. (2023). Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, 142( res. 604), 5751. doi:10.1182/blood-2023-189814
NLM
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 out. 31 ] Available from: https://doi.org/10.1182/blood-2023-189814
Vancouver
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 out. 31 ] Available from: https://doi.org/10.1182/blood-2023-189814
Artigo de periodico
Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia (2023)
Lima, Keli Cristina de ; Carvalho, Maria Fernanda Lopes ; Pereira-Martins, Diego Antonio ; Nogueira, Frederico Lisboa ; Miranda, Lívia Bassani Lins de ; Mariane Cristina do Nascimento ; Cavaglieri, Rita de Cássia ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: International Journal of Molecular Sciences. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS, APOPTOSE, PROTEÍNAS PROTO-ONCOGÊNICAS, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences, v. 24, n. 23, p. 12 , 2023Tradução . . Disponível em: https://doi.org/10.3390/ijms242316899. Acesso em: 31 out. 2024.
APA
Lima, K. C. de, Carvalho, M. F. L., Pereira-Martins, D. A., Nogueira, F. L., Miranda, L. B. L. de, Mariane Cristina do Nascimento,, et al. (2023). Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences, 24( 23), 12 . doi:10.3390/ijms242316899
NLM
Lima KC de, Carvalho MFL, Pereira-Martins DA, Nogueira FL, Miranda LBL de, Mariane Cristina do Nascimento, Cavaglieri R de C, Schuringa JJ, Rego EM, Machado Neto JA. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia [Internet]. International Journal of Molecular Sciences. 2023 ; 24( 23): 12 .[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/ijms242316899
Vancouver
Lima KC de, Carvalho MFL, Pereira-Martins DA, Nogueira FL, Miranda LBL de, Mariane Cristina do Nascimento, Cavaglieri R de C, Schuringa JJ, Rego EM, Machado Neto JA. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia [Internet]. International Journal of Molecular Sciences. 2023 ; 24( 23): 12 .[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/ijms242316899
Artigo de periodico
Chromomycin A5 induces bona fide immunogenic cell death in melanoma (2022)
Florêncio, Katharine Gurgel Dias ; Edson, Evelline Araújo; Fernandes, Keilla Santana da Silva ; Luiz, João Paulo Mesquita ; Pinto, Francisco das Chagas Lima ; Pessoa, Otília Deusdênia Loiola ; Wilke, Diego Veras ; Cunha, Fernando de Queiroz ; Machado Neto, João Agostinho
Source: Frontiers in Immunology. Unidades: FMRP, ICB
Subjects: FARMACOLOGIA, MELANOMA, ANTIBIÓTICOS, ANTINEOPLÁSICOS, IMUNOTERAPIA, PRODUTOS NATURAIS, CÉLULAS CULTIVADAS DE TUMOR, LINFÓCITOS T, APOPTOSE, ADJUVANTES IMUNOLÓGICOS, QUIMIOTERAPIA, CITOMETRIA DE FLUXO, REAÇÃO EM CADEIA POR POLIMERASE, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FLORÊNCIO, Katharine Gurgel Dias et al. Chromomycin A5 induces bona fide immunogenic cell death in melanoma. Frontiers in Immunology, v. 13, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.941757. Acesso em: 31 out. 2024.
APA
Florêncio, K. G. D., Edson, E. A., Fernandes, K. S. da S., Luiz, J. P. M., Pinto, F. das C. L., Pessoa, O. D. L., et al. (2022). Chromomycin A5 induces bona fide immunogenic cell death in melanoma. Frontiers in Immunology, 13, 1-19. doi:10.3389/fimmu.2022.941757
NLM
Florêncio KGD, Edson EA, Fernandes KS da S, Luiz JPM, Pinto F das CL, Pessoa ODL, Wilke DV, Cunha F de Q, Machado Neto JA. Chromomycin A5 induces bona fide immunogenic cell death in melanoma [Internet]. Frontiers in Immunology. 2022 ; 13 1-19.[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fimmu.2022.941757
Vancouver
Florêncio KGD, Edson EA, Fernandes KS da S, Luiz JPM, Pinto F das CL, Pessoa ODL, Wilke DV, Cunha F de Q, Machado Neto JA. Chromomycin A5 induces bona fide immunogenic cell death in melanoma [Internet]. Frontiers in Immunology. 2022 ; 13 1-19.[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fimmu.2022.941757
Artigo de periodico
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy (2022)
Lima, Keli Cristina de ; Martins, Diego Antonio Pereira ; Miranda, Lívia Bassani Lins De ; Silva, Juan Luiz Coelho ; Leandro, Giovana da Silva ; Weinhäuser, Isabel ; Cavaglieri, Rita de Cássia; Leal, Aline de Medeiros; Silva, Wellington Fernandes da; Lange, Ana Paula Alencar de Lima; Velloso, Elvira Deolinda Rodrigues Pereira ; Rego, Eduardo Magalhães ; Griessinger, Emmanuel ; Hilberink, Jacobien R. ; Ammatuna, Emanuele ; Huls, Gerwin ; Schuringa, Jan Jacob ; Machado Neto, João Agostinho
Source: Blood Cancer Journal. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, HOMEOSTASE, APOPTOSE, MITOCÔNDRIAS, ESPECTROMETRIA DE MASSAS, CROMATOGRAFIA LÍQUIDA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41408-022-00747-w. Acesso em: 31 out. 2024.
APA
Lima, K. C. de, Martins, D. A. P., Miranda, L. B. L. D., Silva, J. L. C., Leandro, G. da S., Weinhäuser, I., et al. (2022). The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, 12, 1-11. doi:10.1038/s41408-022-00747-w
NLM
Lima KC de, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41408-022-00747-w
Vancouver
Lima KC de, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41408-022-00747-w
Artigo de periodico
Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells (2022)
Fernandes, Jaqueline Cristina; Fenerich, Bruna Alves ; Silva, Antônio Bruno Alves; Fonseca, Natasha Peixoto ; Silva, Juan Luiz Coelho ; Scheucher, Priscila Santos ; Rego, Eduardo Magalhães ; Pontes, Lorena Lôbo Figueiredo ; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Toxicology in Vitro. Unidades: FM, FMRP, ICB
Subjects: FARMACOLOGIA, ANTINEOPLÁSICOS, INIBIDORES QUÍMICOS, MEDULA ÓSSEA, CÉLULAS-TRONCO, PROLIFERAÇÃO CELULAR, APOPTOSE, MUTAÇÃO, CÉLULAS MIELOIDES, FATORES DE CRESCIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Jaqueline Cristina et al. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells. Toxicology in Vitro, v. 83, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.tiv.2022.105384. Acesso em: 31 out. 2024.
APA
Fernandes, J. C., Fenerich, B. A., Silva, A. B. A., Fonseca, N. P., Silva, J. L. C., Scheucher, P. S., et al. (2022). Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells. Toxicology in Vitro, 83, 1-7. doi:10.1016/j.tiv.2022.105384
NLM
Fernandes JC, Fenerich BA, Silva ABA, Fonseca NP, Silva JLC, Scheucher PS, Rego EM, Pontes LLF, Machado Neto JA, Traina F. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells [Internet]. Toxicology in Vitro. 2022 ; 83 1-7.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.tiv.2022.105384
Vancouver
Fernandes JC, Fenerich BA, Silva ABA, Fonseca NP, Silva JLC, Scheucher PS, Rego EM, Pontes LLF, Machado Neto JA, Traina F. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells [Internet]. Toxicology in Vitro. 2022 ; 83 1-7.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.tiv.2022.105384
Artigo de periodico
Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms (2022)
Takei, Hisashi; Silva, Juan Luiz Coelho ; Leal, Cristina Tavares; Rocha, Adriana Queiroz Arantes; Bianco, Thiago Mantello ; Welner, Robert S.; Mishima, Yuta ; Kobayashi, Ikei S.; Mullally, Ann ; Lima, Keli Cristina de ; Machado Neto, João Agostinho ; Kobayashi, Susumu S. ; Pontes, Lorena Lobo De Figueiredo
Source: Cancer Science. Unidades: ICB, FMRP, FM
Subjects: FARMACOLOGIA, PROTEÍNAS PROTO-ONCOGÊNICAS, INIBIDORES DE ENZIMAS, MODELOS ANIMAIS DE DOENÇAS, FÁRMACOS, MEDICAMENTO, NEOPLASIAS, PROLIFERAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, CAMUNDONGOS, MUTAÇÃO, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAKEI, Hisashi et al. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Science, v. 113, n. 2, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1111/cas.15210. Acesso em: 31 out. 2024.
APA
Takei, H., Silva, J. L. C., Leal, C. T., Rocha, A. Q. A., Bianco, T. M., Welner, R. S., et al. (2022). Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Science, 113( 2), 1-12. doi:10.1111/cas.15210
NLM
Takei H, Silva JLC, Leal CT, Rocha AQA, Bianco TM, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima KC de, Machado Neto JA, Kobayashi SS, Pontes LLDF. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms [Internet]. Cancer Science. 2022 ; 113( 2): 1-12.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/cas.15210
Vancouver
Takei H, Silva JLC, Leal CT, Rocha AQA, Bianco TM, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima KC de, Machado Neto JA, Kobayashi SS, Pontes LLDF. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms [Internet]. Cancer Science. 2022 ; 113( 2): 1-12.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/cas.15210
Artigo de periodico
Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma (2022)
Hirata, Amanda Soares ; Clair, James J. La ; Jimenez, Paula C. ; Costa-Lotufo, Letícia Veras ; Fenical, William
Source: Marine Drugs. Unidade: ICB
Subjects: FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, PRODUTOS NATURAIS, MELANOMA, NEOPLASIAS CUTÂNEAS, MOLÉCULA, INFECÇÕES BACTERIANAS GRAM-POSITIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Amanda Soares et al. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma. Marine Drugs, v. 20, n. 5, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.3390/md20050301. Acesso em: 31 out. 2024.
APA
Hirata, A. S., Clair, J. J. L., Jimenez, P. C., Costa-Lotufo, L. V., & Fenical, W. (2022). Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma. Marine Drugs, 20( 5), 1-13. doi:10.3390/md20050301
NLM
Hirata AS, Clair JJL, Jimenez PC, Costa-Lotufo LV, Fenical W. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma [Internet]. Marine Drugs. 2022 ; 20( 5): 1-13.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/md20050301
Vancouver
Hirata AS, Clair JJL, Jimenez PC, Costa-Lotufo LV, Fenical W. Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma [Internet]. Marine Drugs. 2022 ; 20( 5): 1-13.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/md20050301
Artigo de periodico-carta/editorial
Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax (2022)
Lima, Keli Cristina de ; Vicari, Hugo Passos ; Carlos, Jorge Antonio Elias Godoy; Silva, Jean Carlos Lipreri da ; Pontes, Lorena Lobo de Figueiredo ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Unidades: FMRP, FM, ICB
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, APOPTOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2021.01.004. Acesso em: 31 out. 2024. , 2022
APA
Lima, K. C. de, Vicari, H. P., Carlos, J. A. E. G., Silva, J. C. L. da, Pontes, L. L. de F., Rego, E. M., & Machado Neto, J. A. (2022). Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2021.01.004
NLM
Lima KC de, Vicari HP, Carlos JAEG, Silva JCL da, Pontes LL de F, Rego EM, Machado Neto JA. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 1): 124-127.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2021.01.004
Vancouver
Lima KC de, Vicari HP, Carlos JAEG, Silva JCL da, Pontes LL de F, Rego EM, Machado Neto JA. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 1): 124-127.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2021.01.004
Artigo de periodico
AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy (2022)
Almeida, Larissa Costa de ; Carlos, Jorge Antonio Elias Godoy ; Teixeira, Paula Rezende ; Machado Neto, João Agostinho ; Costa-Lotufo, Letícia Veras
Source: Life Sciences. Unidade: ICB
Subjects: FARMACOLOGIA, NEOPLASIAS COLORRETAIS, PROTEÍNAS PROTO-ONCOGÊNICAS, RNA MENSAGEIRO, APOPTOSE, ANTINEOPLÁSICOS, CÉLULAS CULTIVADAS DE TUMOR, INIBIDORES DE ENZIMAS, ATIVAÇÃO ENZIMÁTICA, PROTEÍNAS QUINASES, TRANSDUÇÃO DE SINAL CELULAR, CARCINOGÊNESE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Larissa Costa de et al. AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy. Life Sciences, v. 308, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2022.120911. Acesso em: 31 out. 2024.
APA
Almeida, L. C. de, Carlos, J. A. E. G., Teixeira, P. R., Machado Neto, J. A., & Costa-Lotufo, L. V. (2022). AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy. Life Sciences, 308, 1-9. doi:10.1016/j.lfs.2022.120911
NLM
Almeida LC de, Carlos JAEG, Teixeira PR, Machado Neto JA, Costa-Lotufo LV. AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy [Internet]. Life Sciences. 2022 ; 308 1-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.lfs.2022.120911
Vancouver
Almeida LC de, Carlos JAEG, Teixeira PR, Machado Neto JA, Costa-Lotufo LV. AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy [Internet]. Life Sciences. 2022 ; 308 1-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.lfs.2022.120911
Artigo de periodico
Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia (2022)
Silva, Jean Carlos Lipreri da ; Araujo, Felipe Saldanha ; Melo, Raphael Costa Bandeira de; Vicari, Hugo Passos ; Carvalho, Amandda Evelin Silva ; Rego, Eduardo Magalhães ; Buccheri, Valeria ; Machado Neto, João Agostinho
Source: Life Sciences. Unidades: FM, ICB
Subjects: FARMACOLOGIA, DOENÇAS HEMATOLÓGICAS, LEUCEMIA, LINFÓCITOS B, ONCOGENES, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, LINFOMA, MEMBRANA PLASMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jean Carlos Lipreri da et al. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, v. 311, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2022.121146. Acesso em: 31 out. 2024.
APA
Silva, J. C. L. da, Araujo, F. S., Melo, R. C. B. de, Vicari, H. P., Carvalho, A. E. S., Rego, E. M., et al. (2022). Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, 311, 1-9. doi:10.1016/j.lfs.2022.121146
NLM
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146
Vancouver
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146
Trabalho de evento-resumo periodico
A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells (2022)
Jaeg, Carlos; Almeida, LC; Lima, K; Tavares, M. T; Waitman, K. B; Costa-Lotufo, Letícia Veras ; Parise Filho, Roberto ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO). Unidades: ICB, FCF
Subjects: INIBIDORES DE ENZIMAS, APOPTOSE, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAEG, Carlos et al. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2022.09.267. Acesso em: 31 out. 2024. , 2022
APA
Jaeg, C., Almeida, L. C., Lima, K., Tavares, M. T., Waitman, K. B., Costa-Lotufo, L. V., et al. (2022). A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2022.09.267
NLM
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267
Vancouver
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267
Artigo de periodico
Targeting Ca2+ and mitochondrial homeostasis by antipsychotic thioridazine in Leukemia cells (2022)
Moraes, Vivian W. R.; Santos, Vivian M.; Suarez, Eloah R. ; Ferraz, Letícia Silva ; Lopes, Rayssa de Mello ; Mognol, Giuliana P.; Campeiro, Joana D. ; Machado Neto, João Agostinho ; Nascimento, Fabio D.; Hayashi, Mirian A. F. ; Tersariol, Ivarne Luis dos Santos ; Newmeyer, Donald D.; Rodrigues, Tiago
Source: Life. Unidade: ICB
Subjects: FARMACOLOGIA, LEUCEMIA, HOMEOSTASE, QUIMIOTERÁPICOS, CITOTOXICIDADE IMUNOLÓGICA, RETÍCULO ENDOPLASMÁTICO, REAÇÃO EM CADEIA POR POLIMERASE, APOPTOSE, MITOCÔNDRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Vivian W. R. et al. Targeting Ca2+ and mitochondrial homeostasis by antipsychotic thioridazine in Leukemia cells. Life, v. 12, n. 10, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.3390/life12101477. Acesso em: 31 out. 2024.
APA
Moraes, V. W. R., Santos, V. M., Suarez, E. R., Ferraz, L. S., Lopes, R. de M., Mognol, G. P., et al. (2022). Targeting Ca2+ and mitochondrial homeostasis by antipsychotic thioridazine in Leukemia cells. Life, 12( 10), 1-20. doi:10.3390/life12101477
NLM
Moraes VWR, Santos VM, Suarez ER, Ferraz LS, Lopes R de M, Mognol GP, Campeiro JD, Machado Neto JA, Nascimento FD, Hayashi MAF, Tersariol IL dos S, Newmeyer DD, Rodrigues T. Targeting Ca2+ and mitochondrial homeostasis by antipsychotic thioridazine in Leukemia cells [Internet]. Life. 2022 ; 12( 10): 1-20.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/life12101477
Vancouver
Moraes VWR, Santos VM, Suarez ER, Ferraz LS, Lopes R de M, Mognol GP, Campeiro JD, Machado Neto JA, Nascimento FD, Hayashi MAF, Tersariol IL dos S, Newmeyer DD, Rodrigues T. Targeting Ca2+ and mitochondrial homeostasis by antipsychotic thioridazine in Leukemia cells [Internet]. Life. 2022 ; 12( 10): 1-20.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/life12101477
Artigo de periodico
Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells (2021)
Vicari, Hugo Passos ; Lima, Keli ; Gomes, Ralph da Costa ; Fernandes, Daniara Cristina ; Silva, Jean Carlos Lipreri da ; Rodrigues Junior, Manoel Trindade; Oliveira, Aline Silva Barroso de; Santos, Ricardo Nascimento dos ; Andricopulo, Adriano Defini ; Coelho, Fernando; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho
Source: European Journal of Pharmacology. Unidades: IFSC, ICB
Subjects: FARMACOLOGIA, QUIMIOTERAPIA, LEUCEMIA MIELOIDE AGUDA, CÉLULAS SANGUÍNEAS, ANTINEOPLÁSICOS, ONCOGENES, CITOTOXICIDADE IMUNOLÓGICA, LEUCÓCITOS, PROLIFERAÇÃO CELULAR, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICARI, Hugo Passos et al. Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells. European Journal of Pharmacology, v. 894, p. 173853-1-173853-10, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2021.173853. Acesso em: 31 out. 2024.
APA
Vicari, H. P., Lima, K., Gomes, R. da C., Fernandes, D. C., Silva, J. C. L. da, Rodrigues Junior, M. T., et al. (2021). Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells. European Journal of Pharmacology, 894, 173853-1-173853-10. doi:10.1016/j.ejphar.2021.173853
NLM
Vicari HP, Lima K, Gomes R da C, Fernandes DC, Silva JCL da, Rodrigues Junior MT, Oliveira ASB de, Santos RN dos, Andricopulo AD, Coelho F, Costa-Lotufo LV, Machado Neto JA. Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells [Internet]. European Journal of Pharmacology. 2021 ; 894 173853-1-173853-10.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejphar.2021.173853
Vancouver
Vicari HP, Lima K, Gomes R da C, Fernandes DC, Silva JCL da, Rodrigues Junior MT, Oliveira ASB de, Santos RN dos, Andricopulo AD, Coelho F, Costa-Lotufo LV, Machado Neto JA. Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells [Internet]. European Journal of Pharmacology. 2021 ; 894 173853-1-173853-10.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejphar.2021.173853
Artigo de periodico
Targeting glioma cells by antineoplastic activity of reversine (2021)
Hirakata, Camila Yumi Soares ; Lima, Keli ; Almeida, Bruna Oliveira De ; Miranda, Lívia Bassani Lins De ; Florêncio, Katharine Gurgel Dias ; Furtado, Luciana Costa ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho
Source: Oncology Letters. Unidade: ICB
Subjects: FARMACOLOGIA, APOPTOSE, PROTEÍNAS QUINASES, GLIOMA, NEOPLASIAS CEREBRAIS, CÉLULAS CULTIVADAS DE TUMOR, ANTINEOPLÁSICOS, REAÇÃO EM CADEIA POR POLIMERASE, WESTERN BLOTTING
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRAKATA, Camila Yumi Soares et al. Targeting glioma cells by antineoplastic activity of reversine. Oncology Letters, v. 22, n. 2, p. 1-9, 2021Tradução . . Disponível em: https://doi.org/10.3892/ol.2021.12871. Acesso em: 31 out. 2024.
APA
Hirakata, C. Y. S., Lima, K., Almeida, B. O. D., Miranda, L. B. L. D., Florêncio, K. G. D., Furtado, L. C., et al. (2021). Targeting glioma cells by antineoplastic activity of reversine. Oncology Letters, 22( 2), 1-9. doi:10.3892/ol.2021.12871
NLM
Hirakata CYS, Lima K, Almeida BOD, Miranda LBLD, Florêncio KGD, Furtado LC, Costa-Lotufo LV, Machado Neto JA. Targeting glioma cells by antineoplastic activity of reversine [Internet]. Oncology Letters. 2021 ; 22( 2): 1-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.3892/ol.2021.12871
Vancouver
Hirakata CYS, Lima K, Almeida BOD, Miranda LBLD, Florêncio KGD, Furtado LC, Costa-Lotufo LV, Machado Neto JA. Targeting glioma cells by antineoplastic activity of reversine [Internet]. Oncology Letters. 2021 ; 22( 2): 1-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.3892/ol.2021.12871
Artigo de periodico
Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors (2021)
Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Kronenberger, Thales ; Ferreira, Glaucio Monteiro ; Divitiis, Thainá Fujii de ; Toledo, Mônica Franco Zannini Junqueira ; Hassimotto, Neuza Mariko Aymoto ; Machado Neto, João Agostinho ; Costa-Lotufo, Letícia Veras ; Parise Filho, Roberto
Source: Bioorganic and Medicinal Chemistry. Unidades: FCF, ICB, PRÓ-G
Subjects: CITOTOXICIDADE IMUNOLÓGICA, ENZIMAS, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Maurício Temotheo et al. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, v. 35, p. 1-42 art. 116085, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2021.116085. Acesso em: 31 out. 2024.
APA
Tavares, M. T., Almeida, L. C. de, Kronenberger, T., Ferreira, G. M., Divitiis, T. F. de, Toledo, M. F. Z. J., et al. (2021). Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, 35, 1-42 art. 116085. doi:10.1016/j.bmc.2021.116085
NLM
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Costa-Lotufo LV, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085
Vancouver
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Costa-Lotufo LV, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration